Genetic Features of a Representative Panel of 110 Meningococcal B Isolates to Assess the Efficacy of Meningococcal B Vaccines
ABSTRACT Predictions of vaccine efficacy against Neisseria meningitidis serogroup B (NmB) disease are hindered by antigenic variability, limiting the representativeness of individual NmB isolates. A qualitative human serum bactericidal assay using endogenous complements of individual subjects (enc-h...
Main Authors: | Alessandro Muzzi, Margherita Bodini, Nadav Topaz, Vega Masignani, Kumaran Vadivelu, Henju Marjuki, Xin Wang, Laura Serino, Duccio Medini |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-10-01
|
Series: | mSphere |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/msphere.00385-22 |
Similar Items
-
Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review
by: George Kassianos, et al.
Published: (2023-07-01) -
Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis
by: Elizabeth R. Packnett, et al.
Published: (2023-01-01) -
Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020
by: Alessandro Muzzi, et al.
Published: (2024-06-01) -
Introduction of a second MenB vaccine into Europe – needs and opportunities for public health
by: Jamie Findlow, et al.
Published: (2019-03-01) -
Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease
by: Elizabeth M. La, et al.
Published: (2019-04-01)